Stock listing

Ventripoint Diagnostics Ltd.

Selected listing: A2ABKZ · LSX · EUR · DE

Ventripoint Diagnostics Ltd. (LS Exchange: A2ABKZ), Health Technology. Latest release Oct 6, 2026: Ventripoint Provides Corporate Update and Announces…

A2ABKZ:LSXEURDEUpdated September 25, 2026

Ticker: LS Exchange: A2ABKZ
Asset type: Stock
Sector: Health Technology
Industry: Medical Specialties
Exchange: LS Exchange
Currency: EUR

Latest news from Ventripoint Diagnostics Ltd.

Ventripoint Provides Corporate Update and Announces Shareholder Videoconference Call

October 6, 2026

Ventripoint Announces Successful Completion of Annual Quality and Regulatory Audits

September 24, 2026

Ventripoint Closes First Tranche of Private Placement Financing and Engages Strategic Advisors to Accelerate Commercialization of VMS+(TM) Technology

September 8, 2026

UniDoc Health Signs MOU with Ventripoint Diagnostics to Evaluate Remote Cardiac Assessment and Screening Platform

August 20, 2026

Ventripoint Expands Subscription Access for FDA-Cleared AI Cardiac Imaging

August 12, 2026

All Ventripoint Diagnostics Ltd. news →

Research Ventripoint Diagnostics Ltd.

Ventripoint Diagnostics Ltd. company profile

View the public company page for Ventripoint Diagnostics Ltd. on 6ix.

Ventripoint Diagnostics Ltd. news

Read company news and market updates connected to Ventripoint Diagnostics Ltd..

Ventripoint Diagnostics Ltd. investor events

Find investor webinars, events, and replay context for Ventripoint Diagnostics Ltd..